The Diaceutics Podcast
The Diaceutics Podcast
Podcast Description
🎙️ The Diaceutics Podcast: Diagnostics, Data & Commercial Strategy
Welcome to The Diaceutics Podcast — where diagnostics meet data, and strategy meets impact.
In each episode, we explore how Diaceutics is helping pharma and biotech companies navigate the complex journey from biomarker discovery to therapy adoption. Whether it’s oncology, rare disease, or emerging therapeutic areas, we dive into the real-world challenges and innovations shaping the future of healthcare.
From diagnostic testing and commercialization to AI, real-time data, and global market access — this is your front-row seat to the evolving world of precision-driven healthcare.
www.diaceutics.com
Podcast Insights
Content Themes
The podcast covers a variety of themes central to precision medicine, including diagnostic testing, AI in healthcare, and therapeutic strategy. Notable episode examples include insights from ASCO 2025 focusing on actionable strategies for pharma teams, the impact of novel therapies like gene and cell therapies, and advances in ctDNA detection methods.
🎙️ The Diaceutics Podcast: Diagnostics, Data & Commercial Strategy
Welcome to The Diaceutics Podcast — where diagnostics meet data, and strategy meets impact.
In each episode, we explore how Diaceutics is helping pharma and biotech companies navigate the complex journey from biomarker discovery to therapy adoption. Whether it’s oncology, rare disease, or emerging therapeutic areas, we dive into the real-world challenges and innovations shaping the future of healthcare.
From diagnostic testing and commercialization to AI, real-time data, and global market access — this is your front-row seat to the evolving world of precision-driven healthcare.
www.diaceutics.com
Join Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, and Kevin Entwistle, VP of Precision Medicine Strategy, as they unpack the key takeaways from ASCO 2025 and explore how the latest oncology data can shape your commercial strategy.
In this expert-led discussion, you’ll hear about:
- How to translate scientific insights into actionable strategies for pharma and biotech teams
- Commercial implications of novel ADCs, gene & cell therapies, and multi-cancer detection
- The growing impact of AI and computational pathology in clinical decision-making
- Breakthrough clinical data from trials like SERENA-6, MATTERHORN, ATOMIC, and AMPLITUDE
- Advances in ctDNA and MRD detection, including MONSTAR-SCREEN-3 and DYNAMIC-III
- The evolving role of biomarkers and diagnostic testing in precision medicine
Connect with the Speakers
- Susanne Munksted: https://www.linkedin.com/in/susanne-munksted-9169031/
- Kevin Entwistle: https://www.linkedin.com/in/kevin-entwistle-73335520/
🌐 Learn more about Diaceutics: https://www.diaceutics.com/contact-us
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.